We are live on ! Find out more
ABMD

Abiomed Inc

Delisted

ABMD was delisted on the 21st of December, 2022.

274 hedge funds and large institutions have $3.94B invested in Abiomed Inc in 2016 Q1 according to their latest regulatory filings, with 61 funds opening new positions, 109 increasing their positions, 83 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed

423% more call options, than puts

Call options by funds: $51.4M | Put options by funds: $9.84M

85% more first-time investments, than exits

New positions opened: 61 | Existing positions closed: 33

31% more repeat investments, than reductions

Existing positions increased: 109 | Existing positions reduced: 83

10% more funds holding

Funds holding: 249274 (+25)

10% more capital invested

Capital invested by funds: $3.58B → $3.94B (+$358M)

0% more funds holding in top 10

Funds holding in top 10: 88 (0)

Holders
274
Holders Change
+25
Holders Change %
+10.04%
% of All Funds
7.3%
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.21%
New
61
Increased
109
Reduced
83
Closed
33
Calls
$51.4M
Puts
$9.84M
Net Calls
+$41.6M
Net Calls Change
+$41M
Name Holding Trade Value Shares
Change
Change in
Stake
CWM
226
Cabot Wealth Management
Massachusetts
$211K -$8.44K -100 -4%
CIM
227
Calvert Investment Management
Maryland
$211K +$188K +2,222 New
IC
228
Intersect Capital
California
$209K +$186K +2,205 New
BRWA
229
B. Riley Wealth Advisors
Florida
$206K +$184K +2,177 New
US Bancorp
230
US Bancorp
Minnesota
$205K -$73.4K -870 -29%
AWM
231
Affinity Wealth Management
Delaware
$200K +$178K +2,113 New
FANJ
232
Financial Architects (New Jersey)
New Jersey
$190K +$169K +2,000 New
AIM
233
Advantage Investment Management
Iowa
$181K +$9.88K +117 +7%
GGHC
234
Gilder Gagnon Howe & Co
New York
$180K -$2.7K -32 -2%
LIA
235
LS Investment Advisors
Michigan
$147K +$11K +130 +9%
Bessemer Group
236
Bessemer Group
New Jersey
$116K +$50.2K +595 +94%
Zurich Cantonal Bank
237
Zurich Cantonal Bank
Switzerland
$110K
Creative Planning
238
Creative Planning
Kansas
$104K -$50.6K -600 -35%
GS
239
GAM Systematic
United Kingdom
$92K -$245K -2,899 -75%
Mitsubishi UFJ Asset Management
240
Mitsubishi UFJ Asset Management
Japan
$91K +$3.29K +39 +4%
PAM
241
Paradigm Asset Management
New York
$80.7K +$4.3K +51 +6%
AIM
242
Acrospire Investment Management
Illinois
$66K +$59.1K +700 New
IA
243
IFP Advisors
Florida
$64K +$17K +201 +1,005%
HNB
244
Huntington National Bank
Ohio
$61K +$54.9K +650 +325%
BNP Paribas Financial Markets
245
BNP Paribas Financial Markets
France
$60.7K -$660K -7,820 -92%
DADC
246
D.A. Davidson & Co
Montana
$58K +$11K +130 +27%
Group One Trading
247
Group One Trading
Illinois
$50K -$486K -5,763 -92%
Nisa Investment Advisors
248
Nisa Investment Advisors
Missouri
$47K +$42.2K +500 New
CCMW
249
Cypress Capital Management (Wyoming)
Wyoming
$41.2K +$36.7K +435 New
AssetMark Inc
250
AssetMark Inc
California
$31K -$43.7K -518 -61%

ABMD Hedge Fund Activity: Q1 2016 in Review

274 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q1 2016, worth a combined $3.94B — up 10% from $3.58B a quarter earlier.

Buyers outnumbered sellers: 61 funds opened new ABMD positions and 33 closed out — a net gain of 28 holders — while 109 added to existing stakes and 83 trimmed.

The largest buyer was 1832 Asset Management, opening a new position worth an estimated $67.6M. The largest seller was Essex Woodlands Management, cutting an estimated $59.1M.

  • 274 institutional investors held Abiomed Inc (ABMD) as of Q1 2016, up from 249 in Q4 2015.
  • Funds reported $3.94B of Abiomed Inc stock for Q1 2016, up 10% quarter-over-quarter.
  • 61 funds opened new Abiomed Inc positions in Q1 2016 and 33 closed out, a net change of +28 holders.
  • The largest Abiomed Inc buyer in Q1 2016 was 1832 Asset Management, an estimated $67.6M added.
  • The largest Abiomed Inc seller in Q1 2016 was Essex Woodlands Management, an estimated $59.1M sold.

Based on aggregated 13F filings for Q1 2016.